ANVISA new rules allowing changes on marketing approval “waiting list”
On August 15, 2025, the Brazilian Food and Drug Administration (ANVISA) unveiled its Operational Tactical Plan for 2025-2026, aimed at temporarily…
RNA Law is a leading Brazilian law firm handling complex litigation, patent prosecution, and regulatory law. Learn more at RNA.law
Popular articles from this firm
